AD
ADSEW
Ads-Tec Energy Public Ltd Co
$0.7799
0.00%
$35.3M
No data for this timeframe.
Vol
Market Cap$35.3M
Cap SizeNano Cap
SEC Reports2
Exchange Nasdaq·Sector Miscellaneous Electrical Machinery, Equipment & Supplies·Inc. L2·CIK 0001879248·Prev Close $0.7799
Recent Activity
May 29, 2026
SEC
ADS-TEC Energy entered into a subscription agreement with Svelland Global Trading Master Fund and Mirabella Financial Se
6-K — Impact 6/10
Apr 13, 2026
SEC
Ads-Tec Energy reported a sharp decline in 2025 revenue to €31.6M from €110M in 2024 due to a key customer's insolvency
6-K — Impact 6/10
Latest Reports
BEARISH
6-K
6/10
ADS-TEC Energy entered into a subscription agreement with Svelland Global Trading Master Fund and Mirabella Financial Se
May 29, 2026
BEARISH
6-K
6/10
Ads-Tec Energy reported a sharp decline in 2025 revenue to €31.6M from €110M in 2024 due to a key customer's insolvency
Apr 13, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
2 SEC filing reports analyzed. Sentiment: 0 bullish, 2 bearish, 0 mixed, 0 neutral. Avg impact: 6.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.